Global Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Rocket Pharmaceuticals

Market Cap: US$344.2m

Operates as a late-stage biotechnology company that focuses on developing gene therapies for rare and devastating diseases in the United States.

Savara

Market Cap: US$731.1m

A clinical stage biopharmaceutical company, focuses on rare respiratory diseases.

Zymeworks

Market Cap: US$1.2b

A clinical-stage biotechnology company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer, and autoimmune and inflammatory diseases (AIID).

Bioventix

Market Cap: UK£129.3m

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide.

Arvinas

Market Cap: US$569.0m

A clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins.

SCYNEXIS

Market Cap: US$45.3m

A biotechnology company, develops medicines to overcome and prevent difficult-to-treat and drug-resistant infections in the United States.

Compass Therapeutics

Market Cap: US$598.8m

A clinical-stage oncology-focused biopharmaceutical company, engages in the development of antibody-based therapeutics for the treatment of various human diseases in the United States.

Evaxion

Market Cap: US$28.6m

A clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines.

Acrivon Therapeutics

Market Cap: US$48.4m

A clinical stage biopharmaceutical company, discovers and develops oncology medicines for patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its generative phosphoproteomics platform.

Processa Pharmaceuticals

Market Cap: US$9.7m

A clinical stage biopharmaceutical company, develops chemotherapy drugs to improve the safety and efficacy of cancer treatment.

Sensei Biotherapeutics

Market Cap: US$11.1m

A clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients.

MediPharm Labs

Market Cap: CA$29.5m

Operates as a pharmaceutical company that produces and sells purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally.

Futura Medical

Market Cap: UK£10.0m

Research, develops, and commercializes pharmaceutical and healthcare products for sexual health.

Cardiff Oncology

Market Cap: US$135.7m

A clinical-stage biotechnology company, develops novel therapies for the treatment of various cancers.

West Pharmaceutical Services

Market Cap: US$18.3b

Designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.

Infant Bacterial Therapeutics

Market Cap: SEK 948.4m

Operates as a clinical stage pharmaceutical company develops and markets drugs to prevent serious neonatal diseases affecting premature infants in Sweden.

Pharvaris

Market Cap: US$1.8b

A late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases.

Strategic Partners

Market Cap: DKK 36.7m

Does not have significant operations.

Petros Pharmaceuticals

Market Cap: US$1.1m

A healthcare technology company, focuses on developing and licensing proprietary SaaS platform and Software as a medical device web application designed to assist pharmaceutical companies.

Klotho Neurosciences

Market Cap: US$29.3m

Develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders.

Edesa Biotech

Market Cap: US$17.2m

A clinical-stage biopharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products for inflammatory and immune-related diseases.

Anebulo Pharmaceuticals

Market Cap: US$100.2m

A clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the United States.

Tvardi Therapeutics

Market Cap: US$345.2m

A clinical-stage biopharmaceutical company, engages in the development of novel, oral, and small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need in the United States.

Cullinan Therapeutics

Market Cap: US$353.9m

A clinical-stage biopharmaceutical company, develops therapies for autoimmune diseases and cancer in the United States.

Maze Therapeutics

Market Cap: US$1.2b

A clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of renal, cardiovascular, related metabolic diseases, and obesity in the United States.

Metsera

Market Cap: US$5.5b

A clinical-stage biotechnology company, develops injectable and oral nutrient stimulated hormone analog peptides to treat obesity, overweight, and related diseases.

Protalix BioTherapeutics

Market Cap: US$162.7m

A biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system.

Veracyte

Market Cap: US$2.6b

Operates as a diagnostics company in the United States and internationally.

Photocure

Market Cap: NOK 1.5b

Engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products.

Absci

Market Cap: US$396.2m

Operates as a data-first generative artificial intelligence (AI) drug creation company in the United States.

Dicot Pharma

Market Cap: SEK 1.7b

Engages in the development of pharmaceutical products in Sweden.

Rapid Micro Biosystems

Market Cap: US$141.9m

A life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally.

Tharimmune

Market Cap: US$16.0m

A clinical-stage biotechnology company, engages in the development of therapeutic candidates for rare, inflammatory, and oncologic conditions with high unmet need in the United States.

Adicet Bio

Market Cap: US$69.8m

A clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States.

Nautilus Biotechnology

Market Cap: US$103.8m

A development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome.

Korro Bio

Market Cap: US$358.3m

A biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States.